Related by context. All words. (Click for frequent words.) 74 Extending GestatioN 73 PREGNANT PROCHIEVE ® 73 PREGNANT PROCHIEVE Extending GestatioN 69 Demonstrates Positive 68 personalized cellular immunotherapy 67 Phase III Clinical Trial 67 Patient Enrollment 67 First Patient Enrolled 67 Adjuvant Treatment 67 Phase IIb Trial 66 Natural Hormone Replacement 66 Plaque Psoriasis 66 Oral Calcitonin 66 recurrent metastatic ovarian cancer 66 II Clinical Trial 65 vaginal lidocaine product 65 Randomized Double blind 65 Phase III Clinical Trials 65 EnteroMedics proprietary neuroblocking technology 65 Test Detects 65 Hormone Refractory Prostate Cancer 65 Spinal Fractures 65 Successfully Completes Phase 65 Phase 2b Clinical Trial 65 Sleep Disturbances 65 Trial Evaluating 65 Chronic Wounds 65 Phase 2a Trial 65 candidate SMaRT Replacement 65 Randomized Double Blind 65 Phase 2b Trial 65 Meets Primary Endpoint 65 Drug Shows Promise 64 Crofelemer budesonide foam 64 Dose Escalation 64 Drug Prevents 64 Study Shows Promise 64 Phase III Pivotal 64 Phase Ib Clinical Trial 64 Study Evaluating 64 Clinical Outcome 64 pralatrexate injection folate analogue 64 Completes Patient Enrollment 64 malignant mesothelioma Alfacell 64 Oral Fingolimod 64 Treatment Shows Promise 64 Initiates Enrollment 64 Phase IIa Clinical Trial 64 Dr. Gabriel Lasala 64 Vicor Technologies Announces 64 Shows Promise Against 64 Therapy Improves 64 Clinical Trial Evaluating 64 Prolongs Survival 64 Phase III Trial 64 Medicure Announces 64 novel orally inhaled 64 Phase IIb Clinical Trial 64 NDA Submission 64 Guidelines Issued 64 Nicotine Vaccine 64 Post Operative 64 Hormone Receptor Positive 64 Improves Outcomes 64 individualized cellular immunotherapy 64 Treatment Reduces 64 Phase 2a Clinical Trial 64 Therapy Reduces 64 Extracorporeal Shock Wave 64 Completes Enrollment 63 Valve Replacement 63 Phase 1b Clinical Trial 63 Pivotal Phase III 63 See CLINICAL PHARMACOLOGY 63 Initiate Phase III 63 granted Ortec 63 Complicated Skin 63 Testosterone MDTS R 63 Limb Ischemia 63 PRN FDA Approves 63 REMINDER ORLive Presents 63 FDA Approvals 63 Causes Symptoms 63 Submits NDA 63 Fortical ® Unigene nasal 63 Reduces Pain 63 TCA Cellular 63 Demonstrates Sustained 63 Shows Promising 63 Pooled Analysis 63 IND Filing 63 Randomized Clinical Trials 63 Refractory Angina 63 Single Dose 63 Telik Announces 63 Body Slimming 63 evaluating mipomersen 63 Hedgehog Pathway Inhibitor 63 Metastatic Melanoma 63 undergoing elective percutaneous 63 MKC# MKC# PP 63 Synta Announces 63 Intracranial Aneurysms 63 YOUR LOCAL ANIMAL SHELTER 63 Cardiac Stem Cell 63 Enlarged Prostate 63 Guidelines Recommend 63 Placebo Controlled 63 Effectively Treats 63 candidate CRLX# 63 CHAMPION PCI 63 Improves Survival 63 Clinical Study Shows 63 Relapsed Multiple Myeloma 63 Therapeutic Efficacy 62 CYT# potent vascular disrupting 62 Randomized Phase II 62 Immunomedics Announces 62 Confirmatory Phase 62 Bipolar Depression 62 Statin Therapy 62 REVIVE Diabetes 62 Telik logo TELINTRA 62 Zicam Extreme 62 Patients Receiving 62 Treatment Regimen 62 Inhaled Nitric Oxide 62 oral prodrug 62 Systemic Sclerosis 62 Treating Chronic 62 Mg Usa 62 Dupuytren Disease 62 Cardiac Resynchronization 62 ATRA IV 62 Study Demonstrates 62 hypertrichosis occurred 62 Recurrent Breast Cancer 62 Preclinical Data 62 TO AVOID PREGNANCY WHILE 62 toenail onychomycosis 62 Tumor Response 62 Liver Metastases 62 intravesical infusion therapy 62 Demonstrates Efficacy 62 Tyrosine Kinase Inhibitor 62 Testosterone MDTS ® 62 Diabetic Kidney Disease 62 Combination Treatment 62 Prostate Cancer Vaccine 62 Diabetic Foot Ulcer 62 Hormone Replacement 62 budesonide foam 62 Anti Inflammatory Drug 62 Subgroup Analysis 62 Aortic Stenosis 62 Demonstrates Significant 62 Pivotal Phase 62 Investigational Treatment 62 Randomized Controlled Trials 62 Metastatic Renal Cell Carcinoma 62 Diamyd Medical Diamyd 62 systemic Phase 1b 62 Acute Ischemic Stroke 61 Total Knee Arthroplasty 61 Lowers Risk 61 Gastar Exploration Announces 61 Clinical Trial Results 61 Gout Drug 61 By JENNIFER LEARN 61 Relapsing Multiple Sclerosis 61 Metastatic Prostate Cancer 61 Combination REOLYSIN R 61 SPL# Gel vaginal microbicide 61 Second Pivotal Phase 61 Study Showed 61 Tesetaxel 61 Anthrax Toxin 61 Uterine Cancer 61 Lupus Drug 61 innovative Activated Checkpoint 61 Initiates Clinical Trial 61 Chemotherapy Improves 61 Phase 1b clinical trials 61 Preterm Labor 61 dasatinib Sprycel ® 61 Granted Orphan Drug 61 Zemiva ™ 61 Desvenlafaxine Succinate 61 Dose Ranging Study 61 Advanced Melanoma 61 VIVITROL ® 61 Medullary Thyroid Cancer 61 NMT Medical Announces 61 ATS Simulus R 61 Postmenopausal Osteoporosis 61 mecarbil 61 Advanced Ovarian Cancer 61 Teva Provides Update 61 Controlled Study 61 GATTEX TM 61 Colorectal Cancer CRC 61 Male Contraceptive 61 Imaging Techniques 61 External Beam 61 MEK Inhibitor 61 Study Shows Benefits 61 Autologous Stem Cell Transplantation 61 Uterine Fibroid Embolization 61 Slows Progression 61 Phase Ib II 61 plus Copegus R 61 Stem Cell Treatment 61 Appears Safe 61 thrombin inhibiting aptamer 61 Pivotal Trial 61 Osteoporosis Drugs 61 Rheumatoid Arthritis Patients 61 NPS Pharmaceuticals Announces 61 Glufosfamide 61 Newly Diagnosed Breast Cancer 61 Acute Decompensated Heart Failure 61 recombinant PSMA vaccine 61 Heart Failure Patients 61 Aeolus Pharmaceuticals Announces 61 includes TOLAMBA TM 61 Astralis Ltd. 61 Lung Cancer Survival 61 PEGINTRON TM 61 Pemphigus Vulgaris 61 SinuNase TM 61 Empatic ™ 61 Slow Progression 61 Elagolix 61 Predict Risk 61 Disorder FSAD 61 FDA Approves Drug 61 serine protease inhibitor CU# 61 Multicenter Phase 61 Presents Positive 61 evaluating Actimmune 61 dependent kinase inhibitor 61 Arthritis Sufferers 61 clinical trials Archexin 61 Valvular Heart Disease 61 Therapy Shows Promise 61 Corneal Transplant 61 Localized Prostate Cancer 61 3 registrational trial 61 Cholesterol Lowering Drug 61 SurModics Bravo 61 MEND CABG 61 product platforms AZX# 61 BCG refractory carcinoma 61 Hematology Molecular Pathology 61 Prospective Randomized 61 Naive Patients 61 Patients Suffering 61 candidates Augment ™ 61 Placebo Controlled Study 61 Helps Smokers Quit 61 Glaucoma Treatment 61 Pivotal Study 61 Lowering Blood Pressure 60 Non Invasive Treatment 60 Initiates Phase II 60 Levels Linked 60 Induction Therapy 60 Kidney Transplant Patients 60 Using Dip Pen 60 Endologix Powerlink System 60 CYP#A# CYP#D# 60 www.pranabio.com 60 Fibromyalgia Pain 60 Degarelix 60 rash pruritus nausea 60 FDA Accepts 60 SHORT ON CHEDDAR 60 Laryngeal Cancer 60 HER2 Positive 60 Biogen Genentech 60 Prognostic Value 60 Aloprim TM allopurinol sodium 60 ST Segment Elevation 60 Submits Biologics License Application 60 Dose Ranging 60 Renal Cancer 60 Nanophase Announces 60 phase IIb clinical 60 Phase Ib clinical trials 60 Luveniq 60 Randomized Trials 60 Multicenter Randomized Double 60 ALN HPN 60 Phase 2b Study 60 Squamous Cell Carcinoma 60 AAG geldanamycin analog 60 Prostate Cancer Treatment 60 Proves Effective 60 Treatment Approaches 60 Receives CE Marking 60 B Cell Malignancies 60 cardiac myosin activator omecamtiv 60 forodesine purine nucleoside phosphorylase 60 Hypertensive Patients 60 Bazedoxifene 60 INSPIRE Trial Phase III 60 LightPath Technologies Announces 60 Bayer HealthCare Onyx Pharmaceuticals 60 Lowers Blood Pressure 60 Hedgehog Pathway 60 Renal Impairment 60 evaluating picoplatin 60 FOLOTYN ® 60 See WARNINGS 60 EVIZON TM 60 dorzolamide hydrochloride 60 Node Positive 60 TRANSDUR ™ 60 NASH Huntington 60 Migraine Drug 60 Ovitrelle R Serostim 60 Novel Oral 60 ALISTA TM 60 XL# anticancer compounds 60 Malignant Glioma 60 candidates Azedra TM 60 Percutaneous Tibial Nerve Stimulation 60 refractory chronic lymphocytic 60 Clinical Trial Data 60 PROGENSA R 60 Randomized Phase 60 Lymphocytic 60 Augment TM 60 Menopausal Symptoms 60 DIRECT Trial 60 Long Term Efficacy 60 LymphoStat B belimumab 60 Gastrointestinal Stromal Tumors 60 HCV NS5B polymerase 60 EXECUTIVE SUMMARY II 60 Advaxis Phase 60 Sitebrand Announces 60 Subarachnoid Hemorrhage 60 Therapeutic Vaccine 60 BENLYSTA TM 60 brand ciclesonide HFA 60 SinuNase ™ 60 IND Application 60 Randomized Study 60 Traumatic Spinal Cord Injury 60 Osteoarthritis Patients 60 Shows Statistically Significant 60 HCV Protease Inhibitor 60 therapy Tovaxin 60 cancer indications bafetinib 60 Renal Cell Carcinoma 60 syndrome overactive bladder 60 Neoadjuvant Chemotherapy 60 Investigational Compound 60 #:#-#,# CrossRef 60 Excessive Sweating 60 Breast Tumor 60 SPEAR Study 60 Hypoactive Sexual Desire Disorder 60 R Saizen R 60 markets COLAZAL 60 ZEVALIN ® 60 ELADUR ™ 60 Initiates Clinical 60 Intra Arterial 60 Motesanib 60 Dupuytren Contracture 60 ORLive Presents 60 Pivotal Clinical Trial 60 Oral Anticoagulant 60 Eases Pain 60 Initiate Phase 60 Hsp# Inhibitor 60 Physician Insights 60 Schizophrenia Treatment 59 Left Ventricular 59 Prodarsan R 59 lexidronam injection 59 Drug Candidate 59 Gene Variation 59 Overactive Bladder OAB 59 Myocet 59 Symptom Relief 59 Colorectal Adenomas 59 Truvada tablets 59 Enrolling Patients 59 Female Sexual Arousal 59 evaluating intravenous picoplatin 59 benign prostatic hyperplasia enlarged 59 SPRYCEL ® 59 Efficacy Trial 59 Female Stress Urinary 59 CLARITY study 59 FDA Okays 59 vapreotide acetate 59 FDA APPROVES 59 Anti Tumor 59 Transdermal Patch 59 Vertebral Compression Fracture 59 HepeX B TM 59 NicVAX TM 59 phase IIb trial 59 drug pipeline TAFA# 59 CRMD# 59 Inter Citic Reports 59 Vicriviroc 59 Ocrelizumab 59 Depressive Symptoms 59 vaginal candidiasis 59 Immunotherapeutic 59 Sapacitabine 59 Mylan Receives Approval 59 ThermoDox ® clinical 59 Lenocta TM 59 Bone Marrow Transplants 59 XPEL Announces 59 lintuzumab SGN 59 Company Skouries Olympias 59 allosteric modulator PAM 59 Acne Scars 59 RhuDex 59 Gene Mutation Linked 59 Vasogen Announces 59 Helps Relieve 59 R lenalidomide 59 #:#-#,# CrossRef Medline [002] 59 acyclovir Lauriad R 59 NAVISTAR R 59 Male Infertility 59 Anti Tumor Activity 59 Controlled Trial 59 Novel Inhibitor 59 non peptidic protease 59 Am J Geriatr 59 initiate multicenter 59 particularly SANCTURA XR 59 Breast Exams 59 Inflammatory Arthritis 59 ® chorionic gonadotropin 59 Phase 2a clinical trials 59 Adjuvant Chemotherapy 59 Central Retinal Vein 59 Clinically Tested 59 Systematic Review 59 Commences Phase 59 Clot Busting 59 TRANSDUR ® 59 LibiGel ® 59 Elestrin ® 59 Skin Grafts 59 J Am Acad 59 Patients Treated With 59 Thyroid Hormone 59 Unigene nasal calcitonin 59 RAS MAPK pathway 59 LEUKINE 59 JAK Inhibitor 59 Secca System 59 Cerebral Amyloid Angiopathy 59 Prolonged Exposure 59 investigational pharmacologically unique 59 PHASE III 59 include Ischemic Paraplegia 59 Cinacalcet 59 Device Helps 59 TKB# 59 DG# compounds targeting 59 agonistic human 59 interferon alpha IFN 59 clinical trials dacetuzumab SGN 59 Nuvelo Announces 59 Romios Announces 59 Prostate AdenoCarcinoma Treatment 59 Budesonide foam crofelemer 59 Evalve MitraClip R 59 STRIDE PD 59 Hyperparathyroidism 59 R Bortezomib 59 bile duct tumor 59 Medoxomil 59 Surgical Treatment 59 Paclitaxel Carboplatin 59 EntreMed Presents 59 Dyloject TM 59 ORACLE MS 59 Currency Majors Technical 59 read Palintologist 59 Osteoporosis Treatment 59 Aortic Valve Replacement 59 formerly LymphoStat B 59 DermaQuest ™ Skin 59 Antithrombin 59 treatment naive genotype 59 Tuberculosis Vaccine 59 atypical Hemolytic Uremic Syndrome 59 Platelet Inhibition 59 pan histone deacetylase 59 investigational monoclonal antibody 59 Single Incision 59 Topical Cream 59 Newly Diagnosed Multiple Myeloma 59 LungAlert TM 59 coronary stent merged 59 EOTC Family Matters 59 delivery polymer matrix 59 rumpled dresser 59 Benign Prostatic Hyperplasia 59 Advanced Renal Cell 59 Protease Inhibitor 59 vitreoretinal disorders 59 Meta Analysis 59 Initiates Phase III 59 Ovarian Cancers 59 Oral Insulin 59 Metastatic Colorectal Cancer 59 Frozen Shoulder syndrome Adhesive 59 ACTEMRA TM 59 Staphylococcus aureus Immune Globulin 59 M# rationally 59 Pivotal Phase II 59 CCX# B 59 Rheumatoid Arthritis Drug 59 oncolytic virus therapies 59 Relieves Pain 59 BioElectronics Announces 59 Oral Spray 59 Cetaphil R 59 Clinical Trials Update 59 Engl J Med 59 refractory cutaneous T 59 Peginterferon Alfa 2a 59 ADVANCE ILLUMINATE 59 herpetic keratitis 59 * olmesartan medoxomil 59 JAK2 Inhibitor 59 Radiofrequency Ablation 59 Scottish Motion Tabled 59 Ischemic Stroke 59 opioid induced bowel dysfunction 59 commercialize CorMedix drug 59 BRIM2 59 Atypical Hemolytic Uremic Syndrome 59 phase IIb study 59 Shows Efficacy 59 AcryMed Incorporated 59 USP Tablets PEPCID 58 evaluate ZFP Therapeutic 58 cancer neuroendocrine tumor 58 Aggressive Reduction 58 Accelerated Partial Breast Irradiation 58 Treatment Naive Patients 58 ragweed allergy immunotherapeutic 58 PNP inhibitor 58 Diabetic Ulcers 58 CIMZIA ™ 58 Helps Identify 58 Androxal TM 58 Corcept Therapeutics Announces 58 Disease Modifying 58 Receives Orphan Drug Designation 58 treatment naïve genotype 58 Brain Metastases 58 Endometrial Ablation 58 Hepatitis C Genotype 58 Clin J 58 Embolization 58 Vitrasert R 58 GE Healthcare Introduces 58 PORxin TM platforms 58 Nasdaq Deficiency Notice 58 Files IND 58 Decompensated Heart Failure 58 Glatiramer Acetate 58 Autoimmune Disease 58 Prostate Screening 58 HER2 Positive Breast Cancer 58 Ozarelix 58 #:#-#,# [003] 58 IN PATIENTS WITH 58 Cannabinor 58 Entereg R 58 evaluating T DM1 58 Microplasmin 58 Cancer Cachexia 58 Romidepsin 58 angiotensin analog 58 Knee Implant 58 Phase 1a clinical 58 pulmonology portfolio 58 Hematological 58 methylnaltrexone bromide 58 Multiple Ascending Dose 58 Symbioscience WISDOM PANEL 58 complement inhibitor eculizumab 58 Perforomist TM formoterol fumarate 58 Vaccine Candidate 58 Phase Ib clinical 58 AVI BioPharma Announces 58 evaluating pirfenidone 58 targeted radiotherapeutic 58 telomerase therapeutic 58 Hormone Therapy 58 treat dysmenorrhea 58 Cerebril TM 58 Curaxin CBLC# 58 candidate REP# 58 Aflibercept 58 Initiated Phase 58 Zenvia ™ 58 Tezampanel 58 Nymox NX 58 Prognostic Factors 58 Interferon beta 1a 58 vaginally administered lidocaine 58 Receives Approvable Letter 58 Achieves Primary Endpoint 58 alfa 2a 58 Hospital Acquired Pneumonia 58 Follicular Lymphoma 58 Relapse Prevention 58 Proc Am Soc 58 Antigen Specific 58 Matrix Phase 2b 58 Menstrual Pain 58 Growth Hormone Deficiency 58 var arrContent = 58 HDAC Inhibitor 58 Prostate Cancer Recurrence 58 bone marrow reticulin deposition 58 Bone Metastases 58 Custirsen 58 Skin Structure Infections 58 PDX pralatrexate 58 Pruvel TM 58 Demonstrates Potential 58 NU# direct 58 Schizophrenia Drug 58 Phase IIIb 58 RNAi Therapeutics 58 rALLy clinical trial 58 Improve Diagnosis 58 delayed onset CINV 58 via intradermal injections 58 Threshold Pharmaceuticals Announces 58 antibody MAb 58 Molecular Diagnostic Test 58 Capsulitis 58 myocardial infarction ventricular fibrillation 58 Hepatic Encephalopathy 58 var arrMeta = 58 Surgical Technique 58 Interferon Beta 58 Sipuleucel T 58 octreotide implant 58 Therapy Helps 58 Genes Discovered 58 Chronic Sinusitis 58 clinical trials SGN 58 XP# XP# 58 tramiprosate Alzhemed TM 58 IIa Clinical Trial 58 PEGylated Fab fragment 58 investigational humanized monoclonal antibody 58 Therapy RecoveryRx TM 58 Pneumonia Vaccine 58 Enzyme Replacement Therapy 58 accompanying electrolyte abnormalities 58 Hemispherx flagship products 58 Treatment Experienced 58 BLOOM Behavioral modification 58 RNAi Therapeutic 58 ® decitabine 58 Breast Cancer Treatment 58 Preclinical Study 58 AirBoss Announces 58 lenalidomide Revlimid R 58 CINQUIL 58 Overactive Bladder 58 oral nucleoside analogue 58 Topical Treatment 58 Phase #b/#a clinical 58 Alternative Treatments 58 antiangiogenesis therapies 58 Replacement Therapy 58 Phase Ib study 58 FDA Approves Novel 58 Prostate Cancer Progression 58 TRISCUIT crackers 58 Helps Predict 58 de novo kidney transplant 58 Catheter Ablation 58 phase Ib 58 Brentuximab Vedotin SGN 58 Electrical Stimulation 58 First Patient Dosed 58 com BlackSingles.com R 58 Antiangiogenic 58 Golimumab 58 next generation URAT1 58 Pivotal Trials 58 Stent Thrombosis 58 unique alkylating agent 58 Immunosuppressant 58 dimebon latrepirdine 58 TNFerade TM 58 Phase IIb trials 58 structure infections ABSSSI 58 DIFICID ™ 58 trial evaluating PRX# 58 polyneuropathy HIV DSP 58 carcinoma mCRC 58 number NCT# ClinicalTrials.gov 58 headache nasopharyngitis 58 Progenitor Cells 58 Immunomodulatory 58 oral proteasome inhibitor 58 Dose Finding 58 Entry Inhibitor 58 Imaging Technique 58 HCV RESPOND 2 58 BY KATHERINE MARKS 58 Taro Receives 58 Reduce Inflammation 58 noninvasive outpatient 58 Begins Recording 58 www.signaturegenomics.com 58 Offers Eco Friendly 58 GEM OS2 58 Bio Identical Hormone Replacement 58 Adjunctive 58 ThermoDox R 58 VEGFR2 inhibitor 57 Iron Overload 57 cetuximab Erbitux R 57 modified glutathione analog 57 PROMACTA CARES 57 Arch Dis Child 57 R#/MEM # 57 Pressure Monitoring 57 orally inhaled migraine 57 Syncria albiglutide 57 IIb clinical trial 57 Soy Isoflavones 57 pivotal bioequivalence 57 Venous Thromboembolism 57 Pharmacyclics Announces 57 endoscopic autofluorescence imaging 57 Migraine Treatment 57 Certolizumab 57 Data Suggest 57 Cholesterol Levels SPARCL 57 Fibrin Patch 57 monoclonal antibody IgG1 Mab 57 Reveals Tracklisting 57 Diet Linked 57 Therapeutic Competitors Companies 57 Lower Extremity 57 Ileus 57 Recurrent Glioblastoma 57 signal detection CTSD 57 NEBIDO VANTAS SUPPRELIN LA 57 ANN INTERN MED 57 including eniluracil ADH 57 develop HBV reactivation 57 www.telik.com 57 Induction Chemotherapy 57 Wound Dressing 57 IMPACT IMmunotherapy 57 PATHFINDER ® TRACER 57 Bosutinib 57 Placebo Controlled Trial 57 TRIOLEX ™ 57 dextromethorphan quinidine 57 Anthracycline 57 #-# Full Text 57 var arrUrl = 57 Radiation Induced 57 Tramiprosate ALZHEMED TM 57 Stent Placement 57 Safinamide 57 Xcytrin R 57 robust interlibrary loan 57 Rigel R# 57 overactive bladder AA# 57 European Sepsis Trial 57 Patient Enrolment 57 YONDELIS 57 worsening thrombocytopenia 57 INTEGRILIN R eptifibatide Injection 57 Phase III multicenter 57 Selective Electrochemical Tumor Ablation 57 Raptiva r 57 Announces Tentative Approval 57 TOCOSOL Camptothecin 57 LUNESTA TM 57 Expanded Indication 57 diarrhea predominant irritable 57 Besivance 57 Pertuzumab 57 arsenic trioxide injection 57 HCl Injection 57 Eluting Stent 57 chemotherapy molecularly targeted 57 Aurora Kinase 57 THAT ARE DIFFICULT TO 57 Hyperthermia Therapy 57 Magnetic Stimulation 57 Genes Identified 57 Luramist TM 57 Cethrin R 57 assessing T DM1 57 Levoleucovorin 57 myelodysplastic myeloproliferative diseases 57 ERBITUX cetuximab 57 galiximab 57 CYP#A# substrate 57 Confocal Microscopy 57 Gentle Path compound 57 Pulmonary Arterial Hypertension 57 www.campaigner.com www.my1voice.com 57 Total Hip Replacement 57 Acute Exacerbations 57 FOLFOX6 chemotherapy regimen 57 HCV SPRINT 57 PMX # heptagonist 57 See CONTRAINDICATIONS 57 generation DACH Platinum 57 Accelr8 Announces 57 Tanespimycin 57 Techni lab 57 BY LINDA SATTER 57 Achillion anticipates 57 knee joints Deflux 57 product Fentanyl TAIFUN 57 Proves Successful 57 IMPACT DCM 57 Phase 2b study 57 Prostate Biopsy 57 Panzem R 57 Abstract Accepted 57 Cetrorelix 57 Stereotactic Body Radiation Therapy 57 Anti CD# Antibody 57 recurrent glioma 57 Volumetric Modulated Arc 57 trastuzumab DM1 T DM1 57 Chronic Cough 57 6 sulfatase 57 Antitumor Activity 57 BEMA Granisetron 57 Clinically Proven 57 Previously Untreated 57 known dihydropyrimidine dehydrogenase 57 inflammatory PDE 57 FEMALES SHOULD BE ADVISED 57 Ann Rheum Dis 57 investigational immunotherapy 57 Non Alcoholic Steatohepatitis 57 adjuvant GIST 57 Nail Fungus 57 AFREZZA TM 57 FOREXYARD Daily Forex 57 irinotecan doxorubicin oxaliplatin paclitaxel 57 sapacitabine CYC# 57 DHEA Supplement Cream 57 endoluminal stent graft 57 data management Clintrial 57 sarcoma melanoma 57 BY VAN JENSEN 57 GLP toxicology studies 57 lucinactant 57 include Phenoptin TM 57 Dementia Related Psychosis 57 Nasal Sprays 57 ongoing Phase IIIb 57 including cyclosporine methotrexate 57 CTA# Injection 57 Cardiac Biomarkers 57 topical non steroidal 57 serum phosphorous 57 Amigal TM 57 evaluating satraplatin 57 Perifosine KRX 57 Cloretazine ® 57 FDA Approvable Letter 57 ALTROPANE R 57 STRATEGY FOR AN OPEN 57 IMPDH inhibitor 57 oral dual endothelin 57 Chronic Heart Failure 57 Vascular Disrupting Agent 57 Spectrum Pharmaceuticals Announces 57 CG# oncolytic virus 57 Toyota Corolla #.#L I4 57 PANVAC VF 57 Efficacy Results 57 Estrogen Therapy 57 Adjuvant Therapy 57 Cellulite Reduction 57 IRX 2 57 Significantly Improved 57 paclitaxel poliglumex 57 Chronic Myeloid Leukemia 57 Muscle Wasting 57 Vascugel 57 E1 INT TM 57 Insulin Sensitivity 57 BLEND OF 57 Array BioPharma Reports 57 Parenteral Nutrition 57 events thrombocytopenia neutropenia 57 resistant hormone refractory 57 Liprotamase 57 Synaptic Plasticity 57 MAGE A3 ASCI 57 Syncria R 57 J Am Coll 57 IIa clinical 57 bevirimat Study 57 humanized interleukin 6 57 miconazole Lauriad ® 57 Phase 2a clinical 57 Myocardial Ischemia 57 Spinal Disc 57 blinded randomized placebo controlled 57 Panzem R NCD 57 Anti Bacterial Envelope 57 IMA# 57 Zenvia Phase III 57 Epithelial Cell 57 Primary Hypercholesterolemia 57 Exelixis compounds 57 Zcom Networks Announces 57 randomized multicenter Phase III 57 CVx ChannelVision Expo 57 Intravitreal 57 Coadministration 57 humanized therapeutic 57 nasal decolonization 57 evaluating ASA# 57 solid tumors ZYBRESTAT 57 CIMZIA TM certolizumab pegol 57 MKC# MT 57 AN# topical anti 57 www.ilgenetics.com 57 Knee Arthritis 57 Oral Compound 57 Simulect 57 CCX# 57 EXPAREL TM 57 Further Validates 57 Unresectable 57 SUPPRELIN R LA 57 Corautus Genetics 57 Pharmacologic 57 FUSILEV enhances 57 Carboplatin Paclitaxel 57 undergoing Percutaneous Coronary 57 albiglutide currently 57 Natural Catastrophe Stress 57 IMiDs R 57 'S ® DOLMIO 57 BY ROB KEYS 57 Diabetic Foot Ulcers 57 PI3K/Akt pathway inhibitor 57 VANTAS ® 57 MelaFind R 57 Investigational Oral 57 evaluating carfilzomib 57 Recession Proofing Your 57 Neovascular Age Related Macular 57 Monotherapy 57 Metabolic Efficiency 57 Invasive Fungal Infections 57 testing huN# DM1 57 JZP 57 Soft Tissue Sarcoma 57 Staff Writer serinaw@nwanews.com 57 Initiate Clinical Trial 57 Spiegelmer ® 57 Confirmatory 57 GREATER HAMILTON 'S 57 Relapsed Refractory 57 evaluating tivozanib 57 DUROS 57 Chemoradiation 57 accumulate preferentially 57 NMDA Receptor 57 TELINTRA R 57 TM Drug Eluting 57 Genetic Markers 57 administering VIVITROL 57 Diabet Med 57 Storage Made Simple